Evidence map›Paper›PMID 18077426›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia.

Todd Lencz, Christophe Lambert, Pamela DeRosse, Katherine E Burdick, T Vance Morgan, John M Kane, Raju Kucherlapati, Anil K Malhotra

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01844700 (1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain), which is not on this map. Cited by 241 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
241citing papers in PubMed, 2 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01844700 phase4terminatednot on this mapstarted 2013, after this paper: background citation

1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain

TypeinterventionalSponsorNorthwell HealthRan2013 to 2014Enrolled14ConditionsHigh Risk MC4R Genotype, Low Risk MC4R Genotype, One Week or Less Antipsychotic Lifetime ExposureArmsZiprasidone, aripiprazole, quetiapine, or risperidone
3 · Its place in the literature

Who cites it

241 citing papers in PubMed, 2 syntheses or guidelines pooled it, 435 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

181 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Todd LenczDepartment of Psychiatry Research, Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, 75-59 263rd Street, Glen Oaks, NY 11004, USA. lencz@lij.edu
Christophe Lambert
Pamela DeRosse
Katherine E Burdick
T Vance Morgan
John M Kane
Raju Kucherlapati
Anil K Malhotra
Albert Einstein College of Medicine · USCenter for Human Genetics · USFeinstein Institute for Medical Research · USHarvard University · USNorthwell Health · USYeshiva University · USZucker Hillside Hospital · US

Funding

Trials Operation UnitP30MH074543 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI KANE, JOHN M · 2005 to 2009
$8.1M
Identifying &Characterizing Prodromal SchizophreniaK01MH065580 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI LENCZ, TODD · 2003 to 2007
$675k
CLINICAL TRIALS IN SCHIZOPHRENIA--MOLECULAR APPROACHESK23MH001760 · NIMH · LONG ISLAND JEWISH MEDICAL CENTER · PI MALHOTRA, ANIL K · 1999 to 2003
$621k
NIMH NIH HHS K01 MH065580NIMH NIH HHS K23 MH001760NIMH NIH HHS MH001760NIMH NIH HHS MH065580NIMH NIH HHS MH074543NIMH NIH HHS P30 MH074543
6 · The paper itself

Abstract

Evolutionarily significant selective sweeps may result in long stretches of homozygous polymorphisms in individuals from outbred populations. We developed whole-genome homozygosity association (WGHA) methodology to characterize this phenomenon in healthy individuals and to use this genomic feature to identify genetic risk loci for schizophrenia (SCZ). Applying WGHA to 178 SCZ cases and 144 healthy controls genotyped at 500,000 markers, we found that runs of homozygosity (ROHs), ranging in size from 200 kb to 15 mb, were common in unrelated Caucasians. Properties of common ROHs in healthy subjects, including chromosomal location and presence of nonancestral haplotypes, converged with prior reports identifying regions under selective pressure. This interpretation was further supported by analysis of multiethnic HapMap samples genotyped with the same markers. ROHs were significantly more common in SCZ cases, and a set of nine ROHs significantly differentiated cases from controls. Four of these 9 "risk ROHs" contained or neighbored genes associated with SCZ (NOS1AP, ATF2, NSF, and PIK3C3). Several of these risk ROHs were very rare in healthy subjects, suggesting that recessive effects of relatively high penetrance may explain a proportion of the genetic liability for SCZ. Other risk ROHs feature haplotypes that are also common in healthy individuals, possibly indicating a source of balancing selection.

Indexed as

Genes, RecessiveGenetic Predisposition to DiseaseHomozygotePenetranceCase-Control StudiesFemaleGenetic MarkersHaplotypesHumansMalePolymorphism, Single NucleotideSchizophreniaWhite PeopleGenetic Markers

Identifiers

PMID18077426
PMCPMC2148402
OpenAlexW2127450586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.